Wednesday 13th December 2017
|Text too small?|
Ebos Group chief executive Patrick Davies has stepped down and will be replaced by chief financial officer John Cullity from March 31 next year, the healthcare and animal products company says.
Davies will work on contract for Ebos "to assist with new and emerging opportunities," the company said. It was his decision to step down, Ebos said.
Davis became CEO in July 2014, having held the top job for six years at Symbion, the pharmaceutical wholesaler and distributor in Australia that Ebos acquired in 2013 for $1.1 billion cash and scrip, a deal which transformed the company and saw profit almost triple in 2014. Symbion’s owner Zuellig Group gained a 40 percent stake in the combined business as a result.
Cullity also joined Ebos in July 2014 after roles at Sigma Pharmaceuticals in Australia and Coca-Cola Co in the US.
Ebos shares last traded at $18.34 and have gained 9.8 percent this year.
No comments yet
MARKET CLOSE: NZ shares up 1%, led by Fisher & Paykel, Kathmandu, Spark
NZ dollar heads for 2% decline as resurgent US yields stoke greenback demand
Former Abano shareholders ordered to pay $429k in disputed takeover costs
Seeka shareholder Farmind to cut stake to reduce foreign ownership
Summerset opens Melbourne office as it looks to Australia for growth
Lees-Galloway signals broader health & safety targets in draft strategy
Veritas in refinancing negotiations as ANZ extends debt for a fourth time
ComCom embarks on fibre study to get a handle on looming new policy framework
NZ posts first trade deficit for March month in 10 years as fuel imports surge
NZ log export market picks up after slowdown ahead of Chinese New Year, traders optimistic